The Fertility Testing Device Market is experiencing growth due to the escalating prevalence of infertility cases, affecting around 60-80 million couples annually. This has led to an increased adoption of fertility testing devices. Manufacturers are focusing on innovations and advancements in these devices, particularly in cost-efficient and accurate ovulation monitors. The market's expansion is driven by the growing demand for user-friendly, home-based testing solutions, catering to couples' needs for better fertility management and family planning options worldwide.
Access Full Report:- https://www.databridgemarketresearch.com/reports/global-fertility-testing-devices-market
Data Bridge Market Research analyses that the Global Fertility Testing Devices Market was valued at USD 500.59 million in 2021 and is expected to reach USD 947.35 million by 2029, registering a CAGR of 8.3% during the forecast period of 2022-2029. Increasing awareness about fertility issues and the availability of fertility testing devices have driven market growth. As people become more knowledgeable about their reproductive health, they are more inclined to seek fertility testing solutions, leading to higher demand for these devices.
Key Findings of the Study
Technological advancements is expected to drive the market's growth rate
Technological advancements have revolutionized fertility testing devices, making them more sophisticated, accurate, and user-friendly. With quicker and more reliable results, these devices offer convenience and ease of use. As a result, a broader consumer base has been attracted to these advanced products, including individuals who may not have considered fertility testing before. The enhanced features and improved performance of these devices have driven market growth as they meet the evolving needs and preferences of consumers seeking reliable reproductive health solutions.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Ovulation Prediction Kit, Fertility Monitor), Mode of Purchase (Over the Counter, Prescription Based), Application (Female Fertility Testing Device, Male Fertility Testing Device), End-User (Home Care Settings, Hospitals, Fertility Clinics, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
Swiss Precision Machining, LLC (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Consumer Healthcare Inc. (U.S.), bioZhena Corporation (U.S.), Fairhaven Health (U.S.), FERTILITY FOCUS LIMITED (UK), Geratherm Medical AG (Germany), The Betty Mills Company, Inc. (U.S.), UEBE Medical GmbH (Germany), AdvaCare Pharma (U.S.), Babystart (UK), Valley Electronics AG (Germany), and Mira Care (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The fertility testing devices market is segmented on the basis of product, mode of purchase, application and end-user.
- On the basis of product, the fertility testing devices market is segmented into ovulation prediction kit, fertility monitor.
- On the basis of mode of purchase, the fertility testing devices market is segmented into over the counter, prescription based.
- On the basis of application, the fertility testing devices market is segmented into female fertility testing device, male fertility testing device.
- On the basis of end-user, the fertility testing devices market is segmented into home care settings, hospitals, fertility clinics, others.
Major Players
Data Bridge Market Research recognizes the following companies as the major global fertility testing devices market players in global fertility testing devices market are Swiss Precision Machining, LLC (Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Consumer Healthcare Inc. (U.S.), bioZhena Corporation (U.S.), Fairhaven Health (U.S.), FERTILITY FOCUS LIMITED (UK), Geratherm Medical AG (Germany), The Betty Mills Company, Inc. (U.S.).
Market Developments
- In February 2021, Fertility Focus and ExSeed Health joined forces, offering combined solutions for couples planning pregnancy. Fertility Focus, known for its OvuSense fertility monitoring system, partnered with ExSeed Health, a home-based sperm testing company. Together, they aim to provide comprehensive fertility support to couples, utilizing their expertise in sperm testing and cycle monitoring technologies.
- In May 2019, Fertility Focus (UK) unveiled the updated OvuSense App v.2, introducing enhanced features for users. The new version offered increased flexibility in data viewing with three different display options, surpassing typical apps. It also provided users with more choices for logging events related to fertility tracking, while ensuring heightened accuracy in cycle monitoring, enhancing the overall user experience.
- In June 2020, Modern Fertility launched pregnancy and ovulation tests, along with a mobile application to centralize all fertility-related data
Regional Analysis
Geographically, the countries covered in the global fertility testing devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America's is the dominant region in the global fertility testing devices market during the forecast period 2022 - 2029
North America's fertility testing devices market is driven by factors such as a higher prevalence of adolescent pregnancy, leading to increased demand for fertility testing solutions. The region's growing awareness of pregnancy testing methods and improving fertility rates also contribute to the rising demand for these devices. These factors combine to establish North America as a dominant player in the market.
Asia-Pacific is estimated to be the fastest-growing region in the global fertility testing devices market for the forecast period 2022 - 2029
In contrast, the Asia-Pacific region is expected to witness substantial growth during the forecast period from 2022 to 2029. The growth can be attributed to the rising demand for self-contained and rapid fertility tests and an increasing trend of delaying first pregnancies within the region. These factors are propelling the adoption of fertility testing devices in Asia-Pacific.
For more detailed information about the Global fertility testing devices market report, click here – https://www.databridgemarketresearch.com/reports/global-fertility-testing-devices-market
